S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in
NYSEARCA:ARKG

ARK Genomic Revolution ETF Stock Forecast, Price & News

$90.33
-5.63 (-5.87 %)
(As of 03/3/2021 12:00 AM ET)
Add
Today's Range
$89.84
Now: $90.33
$95.70
50-Day Range
$93.13
MA: $106.08
$112.47
52-Week Range
$24.00
Now: $90.33
$115.15
Volume6.46 million shs
Average Volume6.24 million shs
Market Capitalization$10.20 billion
P/E RatioN/A
Dividend Yield0.82%
BetaN/A

Basic Details

Issuer ARK
Fund NameARK Genomic Revolution Multi-Sector ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:ARKG
Inception Date10/30/2014
Fund ManagerCatherine D. Wood
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNot Applicable
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$2.85 billion
Average Daily Volume$903,175.10
Discount/Premium0.12%

ETF Expenses

Management Fee0.75%
Other Expenses0.00%
Total Expenses0.75%
Fee Waiver0.00%
Net Expenses0.75%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorARK Investment Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerJane Street

Geographic Exposure of ARKG

Currency Exposure of ARKG

Sector Exposure of ARKG

Industry Exposure of ARKG

$90.33
-5.63 (-5.87 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ARKG News and Ratings via Email

Sign-up to receive the latest news and ratings for ARKG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ARK Genomic Revolution ETF (NYSEARCA:ARKG) Frequently Asked Questions

What stocks does MarketBeat like better than ARK Genomic Revolution ETF?

Wall Street analysts have given ARK Genomic Revolution ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ARK Genomic Revolution ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has ARK Genomic Revolution ETF's stock been impacted by COVID-19 (Coronavirus)?

ARK Genomic Revolution ETF's stock was trading at $32.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ARKG stock has increased by 181.1% and is now trading at $90.33.
View which stocks have been most impacted by COVID-19
.

Is ARK Genomic Revolution ETF a good dividend stock?

ARK Genomic Revolution ETF pays an annual dividend of $0.79 per share and currently has a dividend yield of 0.82%.
View ARK Genomic Revolution ETF's dividend history.

What other stocks do shareholders of ARK Genomic Revolution ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARK Genomic Revolution ETF investors own include Tesla (TSLA), ARK Innovation ETF (ARKK), NVIDIA (NVDA), ARK Next Generation Internet ETF (ARKW), Alibaba Group (BABA), Intel (INTC), PayPal (PYPL), Alphabet (GOOG), Netflix (NFLX) and Square (SQ).

What is ARK Genomic Revolution ETF's stock symbol?

ARK Genomic Revolution ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ARKG."

Who are ARK Genomic Revolution ETF's major shareholders?

ARK Genomic Revolution ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (2.25%), LPL Financial LLC (0.88%), Wells Fargo & Company MN (0.55%), Claraphi Advisory Network LLC (0.37%), Carroll Financial Associates Inc. (0.43%) and Raymond James Financial Services Advisors Inc. (0.26%).

Which major investors are selling ARK Genomic Revolution ETF stock?

ARKG stock was sold by a variety of institutional investors in the last quarter, including Carroll Financial Associates Inc., Cetera Advisor Networks LLC, Advocacy Wealth Management Services LLC, Financial Enhancement Group LLC, ERn Financial LLC, Avestar Capital LLC, Avantax Advisory Services Inc., and Simplex Trading LLC.

Which major investors are buying ARK Genomic Revolution ETF stock?

ARKG stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, LPL Financial LLC, Vontobel Holding Ltd., Wells Fargo & Company MN, FormulaFolio Investments LLC, united american securities inc. d b a uas asset management , Purus Wealth Management LLC, and Raymond James Financial Services Advisors Inc..

How do I buy shares of ARK Genomic Revolution ETF?

Shares of ARKG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ARK Genomic Revolution ETF's stock price today?

One share of ARKG stock can currently be purchased for approximately $90.33.

How much money does ARK Genomic Revolution ETF make?

ARK Genomic Revolution ETF has a market capitalization of $10.20 billion.


This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.